Cargando…

ERCC1 and XRCC1 as biomarkers for lung and head and neck cancer

Advanced stage non-small cell lung cancer and head and neck squamous cell carcinoma are both treated with DNA damaging agents including platinum-based compounds and radiation therapy. However, at least one quarter of all tumors are resistant or refractory to these genotoxic agents. Yet the agents ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vaezi, Alec, Feldman, Chelsea H, Niedernhofer, Laura J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513219/ https://www.ncbi.nlm.nih.gov/pubmed/23226053 http://dx.doi.org/10.2147/PGPM.S20317

Ejemplares similares

ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial
por: Bauman, J E, et al.
Publicado: (2013)

A Comprehensive Evaluation of the Association between Polymorphisms in XRCC1, ERCC2, and XRCC3 and Prognosis in Hepatocellular Carcinoma: A Meta-Analysis
por: Zhao, Yan, et al.
Publicado: (2019)

DNA Repair Genes and Chronic Myeloid Leukemia: ERCC2 (751), XRCC1 (399), XRCC4-Intron 3, XRCC4 (-1394) Gene Polymorphisms
por: Ozdilli, Kursat, et al.
Publicado: (2021)

ERCC1 and XRCC1 but not XPA single nucleotide polymorphisms correlate with response to chemotherapy in endometrial carcinoma
por: Chen, Liang, et al.
Publicado: (2016)

ERCC1, XRCC1 and GSTP1 Single Nucleotide Polymorphisms and Survival of Patients with Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy
por: Zaanan, Aziz, et al.
Publicado: (2014)

ERCC1, XRCC1, and GSTP1 Polymorphisms and Treatment Outcomes of Advanced Epithelial Ovarian Cancer Patients Treated with Platinum-based Chemotherapy
por: Liblab, Salisa, et al.
Publicado: (2020)

Associations between XRCC2 rs3218536 and ERCC2 rs13181 polymorphisms and ovarian cancer
por: Zhang, Wei, et al.
Publicado: (2016)

The Association of ERCC1 and ERCC5 Polymorphisms with Lung Cancer Risk in Han Chinese
por: Lan, Xueling, et al.
Publicado: (2022)

ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines
por: Weaver, David A, et al.
Publicado: (2005)

The genetic variations in DNA repair genes ERCC2 and XRCC1 were associated with the overall survival of advanced non‐small‐cell lung cancer patients
por: Wang, Suhan, et al.
Publicado: (2016)

Association between XRCC1 and ERCC1 single-nucleotide polymorphisms and the efficacy of concurrent radiochemotherapy in patients with esophageal squamous cell carcinoma
por: Huang, Xue, et al.
Publicado: (2017)

Association of XRCC1, XRCC2 and XRCC3 Gene Polymorphism with Esophageal Cancer Risk
por: Kaur, Jagjeet, et al.
Publicado: (2020)

Clinical Perspectives of ERCC1 in Bladder Cancer
por: Koutsoukos, Konstantinos, et al.
Publicado: (2020)

The Relationship between XRCC1 and XRCC3 Gene Polymorphisms and Lung Cancer Risk in Northeastern Chinese
por: Guo, Shujie, et al.
Publicado: (2013)

Haplotype analysis of XRCC2 gene polymorphisms and association with increased risk of head and neck cancer
por: Saeed, Soma, et al.
Publicado: (2017)

Arg399Gln XRCC1 Polymorphism and Risk of Squamous Cell Carcinoma of the Head and Neck in Jordanian Patients
por: Sobiahe, Ammar, et al.
Publicado: (2020)

Single nucleotide polymorphisms (SNPs) of ERCC2, hOGG1, and XRCC1 DNA repair genes and the risk of triple-negative breast cancer in Polish women
por: Smolarz, Beata, et al.
Publicado: (2014)

DNA Repair Gene XRCC1 Polymorphisms and Head and Neck Cancer Risk: An Updated Meta-Analysis Including 16344 Subjects
por: Lou, Yin, et al.
Publicado: (2013)

A Meta-Analysis for Association of XRCC1, XRCC2 and XRCC3 Polymorphisms with Susceptibility to Thyroid Cancer
por: Mandegari, Mohammad, et al.
Publicado: (2021)

Cell cycle association and hypoxia regulation of excision repair cross complementation group 1 protein (ERCC1) in tumor cells of head and neck cancer
por: Dudás, József, et al.
Publicado: (2014)

ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation
por: Jun, H J, et al.
Publicado: (2008)

ERCC1 and ERCC2 Variants Predict Survival in Gastric Cancer Patients
por: Li, Yangkai, et al.
Publicado: (2013)

ERCC1 Cys8092Ala and XRCC1 Arg399Gln Polymorphisms Predict Progression-Free Survival after Curative Radiotherapy for Nasopharyngeal Carcinoma
por: Jin, Hekun, et al.
Publicado: (2014)

Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of Northern Spain
por: Felicitas López-Cima, M, et al.
Publicado: (2007)

Genetic polymorphisms in DNA base excision repair gene XRCC1 and the risk of squamous cell carcinoma of the head and neck
por: Kowalski, Michal, et al.
Publicado: (2009)

Survival association of XRCC1 for patients with head and neck squamous cell carcinoma: A systematic review and meta-analysis
por: Yang, Fan, et al.
Publicado: (2023)

SIRT1 deacetylated and stabilized XRCC1 to promote chemoresistance in lung cancer
por: Yousafzai, Neelum Aziz, et al.
Publicado: (2019)

Mislocalization of XPF-ERCC1 Nuclease Contributes to Reduced DNA Repair in XP-F Patients
por: Ahmad, Anwaar, et al.
Publicado: (2010)

Analysis of ERCC1 and ERCC2 gene variants in osteosarcoma, colorectal and breast cancer
por: GÓMEZ-DÍAZ, BENJAMÍN, et al.
Publicado: (2015)

ERCC1 and TS Expression as Prognostic and Predictive Biomarkers in Metastatic Colon Cancer
por: Choueiri, Michel B., et al.
Publicado: (2015)

The Association Between the XRCC1 Arg399Gln Polymorphism and the Risk of Head and Neck Cancer: An Updated Meta-Analysis Including 14586 Subjects
por: Xia, Shitong, et al.
Publicado: (2021)

Deletion of the Nucleotide Excision Repair Gene Ercc1 Reduces Immunoglobulin Class Switching and Alters Mutations Near Switch Recombination Junctions
por: Schrader, Carol E., et al.
Publicado: (2004)

Diagnostic and Prognostic Potential of Biomarkers CYFRA 21.1, ERCC1, p53, FGFR3 and TATI in Bladder Cancers
por: Matuszczak, Milena, et al.
Publicado: (2020)

The XRCC1 Arg194Trp polymorphism was associated with the risk of head and neck squamous cell carcinoma development: Results from a systematic review and meta‐analysis
por: Mohtasham, Nooshin, et al.
Publicado: (2022)

Association of ERCC1 and ERCC2 polymorphisms with colorectal cancer risk in a Chinese population
por: Ni, Min, et al.
Publicado: (2014)

Genetic polymorphisms and haplotypes of ERCC1 and ERCC2 associated with quality of life, depression, and anxiety status among patients with lung cancer
por: Tang, Yunxiang, et al.
Publicado: (2021)

Broad segmental progeroid changes in short-lived Ercc1(−/Δ7) mice
por: Dollé, Martijn E.T., et al.
Publicado: (2011)

Association between XRCC1 and XRCC3 Polymorphisms with Lung Cancer Risk: A Meta-Analysis from Case-Control Studies
por: Huang, Guohua, et al.
Publicado: (2013)

Association between Single Nucleotide Polymorphisms in ERCC4 and Risk of Squamous Cell Carcinoma of the Head and Neck
por: Yu, Hongping, et al.
Publicado: (2012)

Association between XRCC1 Arg399Gln polymorphism with prognosis of head and neck squamous cell carcinomas: A meta-analysis
por: Najafi-Ghobadi, Khadijeh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i9nqjt7u4iloll6i4d6ko527p2